- Ultragenyx Pharmaceutical Inc. stock price today and history
Ultragenyx Pharmaceutical Inc. (RARE) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Ultragenyx Pharmaceutical Inc. stock price
Ultragenyx Pharmaceutical Inc. latest news:
Ultragenyx proposes to buy all Dimension Therapeutics outstanding common stock for $138 mln
Ultragenyx Pharmaceutical Inc. said early Monday that it has proposed to buy all outstanding common stock of Dimension Therapeutics Inc. for $5.50 per share, or about $138 million. The offer would be offered in cash at close to be effectuated via a tender offer, Ultragenyx said. Dimension Therapeutics shares, which were valued at $4.20 as of Friday's close, were halted in premarket trade Monday. REGENXBIO Inc. said in late August that it planned to buy Dimension Therapeutics for about $3.41 per share, and that the board of directors of both companies had signed on. But Ultragenyx said that its offer represents "premiums of 24% and 48% over the implied value of the all-stock consideration" offered by REGENXBIO. "As such, the proposal would provide Dimension stockholders with an immediate and certain return on their investment in Dimension and constitutes a superior alternative to the REGENXBIO transaction," Ultragenyx said. Dimension Therapeutics shares have surged 236% over the last three months, compared with a 2.8% rise in the S&P 500 . Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Ultragenyx shares drop as muscle-disease drug study fails
Ultragenyx Pharmaceutical Inc. shares fell in the extended session Tuesday after the biotech company said a late-stage clinical trial for its severe muscle disease treatment did not reach its goals. Shares of Ultragenyx dropped 10% to $52.96 after hours following a brief halt. The company said its Phase 3 clinical trial for extended-release aceneuramic acid did not significantly improve strength in patients with GNE Myopathy, a rare disease where muscles cannot modify proteins and fats because of an enzyme deficiency. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Ultrapetrol (Bahamas) LimitedULTR
UMB Financial CorporationUMBF
Umpqua Holdings CorporationUMPQ
Unico American CorporationUNAM
Union Bankshares CorporationUBSH
Union Bankshares, Inc.UNB